Related Experiment Video

Updated: Jun 11, 2026

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
08:53

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency

Published on: September 15, 2021

The 20S proteasome splicing activity discovered by SpliceMet

Juliane Liepe1, Michele Mishto, Kathrin Textoris-Taube

  • 1Institut für Biochemie, Charité, Universitätsmedizin Berlin, Berlin, Germany.

Plos Computational Biology
|July 9, 2010
PubMed

Insights

Researchers developed SpliceMet to identify proteasome-generated spliced peptides (PSP), revealing new insights into proteasome-catalyzed peptide splicing (PCPS) and the 20S proteasome

Area of Science:

  • Proteomics
  • Molecular Biology
  • Immunology

Background:

  • Proteasome-generated spliced peptides (PSP) indicate novel protease activity but their characterization is limited.
  • Previous PSP studies relied on patient-derived cytotoxic T lymphocytes (CTL), hindering systematic investigation.
  • Proteasome-catalyzed peptide splicing (PCPS) requires new methodologies for comprehensive analysis.

Purpose of the Study:

  • To develop a method for unrestricted identification of proteasome-generated spliced peptides (PSP).
  • To systematically investigate proteasome-catalyzed peptide splicing (PCPS) independent of patient samples.
  • To characterize novel spliced peptides generated by the 20S proteasome.

Main Methods:

  • Development of SpliceMet, integrating the ProteaJ algorithm with in vitro proteasomal degradation and mass spectrometry.
  • Analysis of proteasomal processing products from four distinct substrate polypeptides (human tumor and viral antigens).
  • Identification of cis- and trans-spliced peptides generated by PCPS.

Main Results:

  • SpliceMet enabled the identification of fifteen novel spliced peptides.
  • These peptides were generated by PCPS through cis-splicing or trans-splicing from separate substrates.
  • Demonstrated the capability of 20S proteasomes to produce spliced peptides from various antigens.

Conclusions:

  • The 20S proteasome acts as a molecular machine facilitating spliced peptide generation.
  • PCPS produces a diverse pool of novel peptides with potential functional relevance.
  • SpliceMet provides a powerful tool for systematic PSP and PCPS research.

More Related Videos

Using the E1A Minigene Tool to Study mRNA Splicing Changes10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
Pre-mRNA Processing: RNA Splicing01:32

Pre-mRNA Processing: RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...